.
MergerLinks Header Logo

New Deal


Announced

IQuest Enterprises to acquire active pharmaceutical ingredients business from Viatris.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pending

Friendly

Single Bidder

Acquisition

Domestic

India

active pharmaceutical ingredients

Pharmaceuticals

Private

Majority

Synopsis

Edit

IQuest Enterprises, a privately held pharmaceutical company, agreed to acquire active pharmaceutical ingredients business from Viatris, a global healthcare company. Financial terms were not disclosed. "We are excited about our largest investment in the pharmaceutical sector till date. Our investment comes at an opportune time when India is drawing significant attention amongst the global pharma industry. It is also a happy homecoming, in more ways than one, for some of us who have been part of the journey over the last two decades," Gunupati Swathi Reddy, IQuest Enterprises Executive Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US